Direct Medical Costs Associated With Negative Diagnosis of IBS.
Assessment of Direct Medical Costs Associated With Making a Negative Diagnosis of IBS.
1 other identifier
observational
3,000
0 countries
N/A
Brief Summary
The purpose of this study is to calculate the unnecessary costs that are associated with a negative IBS diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2021
CompletedStudy Start
First participant enrolled
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedDecember 3, 2021
November 1, 2021
2.5 years
November 22, 2021
November 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Direct medical costs of diagnostic tools associated with a negative diagnosis of IBS.
Unnecessary costs of diagnostic tools, e.g. endoscopy and radiology in SEK that are associated with a negative IBS diagnosis
2013-2017
Direct medical costs of laboratory tests associated with a negative diagnosis of IBS.
Unnecessary costs of laboratory tests, e.g. liver tests, tests for lactose intolerance, stool samples, food allergy tests and autoimmune serology, in SEK that are associated with a negative IBS diagnosis
2013-2017
Direct medical costs of referrals to specialists associated with a negative diagnosis of IBS.
Unncessary costs of referrals to specialist care. If a patient was referred to a specialist, the costs for the associated diagnostics will be calculated as well.
2013-2017
Study Arms (1)
Patients diagnosed with IBS
Patients diagnosed with IBS within primary care in Region Örebro County between 2013-2017, identified by ICD-code K.58.
Eligibility Criteria
Patients diagnosed with IBS within primary care of Region Örebro County 2013-2017.
You may qualify if:
- All adult patients (both sexes) who were diagnosed with IBS according to ICD-10 within primary care of Region Örebro County 2013-2017.
You may not qualify if:
- Patients \< 18 years or \> 65 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michiel van Nieuwenhoven, M.D. Ph.D.
Region Örebro County
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2021
First Posted
December 3, 2021
Study Start
November 29, 2021
Primary Completion
May 31, 2024
Study Completion
May 31, 2025
Last Updated
December 3, 2021
Record last verified: 2021-11